These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 15523313
1. High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction. Kievit PC, Brouwer MA, Veen G, Karreman AJ, Verheugt FW. Am Heart J; 2004 Nov; 148(5):826-33. PubMed ID: 15523313 [Abstract] [Full Text] [Related]
2. Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial. Brouwer MA, Kievit PC, Dieker HJ, Veen G, Karreman AJ, Verheugt FW. Am Heart J; 2008 Jun; 155(6):1039-46. PubMed ID: 18513517 [Abstract] [Full Text] [Related]
3. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. Brouwer MA, van den Bergh PJ, Aengevaeren WR, Veen G, Luijten HE, Hertzberger DP, van Boven AJ, Vromans RP, Uijen GJ, Verheugt FW. Circulation; 2002 Aug 06; 106(6):659-65. PubMed ID: 12163424 [Abstract] [Full Text] [Related]
4. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis. Veen G, Meyer A, Verheugt FW, Werter CJ, de Swart H, Lie KI, van der Pol JM, Michels HR, van Eenige MJ. J Am Coll Cardiol; 1993 Dec 06; 22(7):1755-62. PubMed ID: 8245325 [Abstract] [Full Text] [Related]
5. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study. Meijer A, Verheugt FW, Werter CJ, Lie KI, van der Pol JM, van Eenige MJ. Circulation; 1993 May 06; 87(5):1524-30. PubMed ID: 8491007 [Abstract] [Full Text] [Related]
6. Adverse long-term effects of reocclusion after coronary thrombolysis. Brouwer MA, Böhncke JR, Veen G, Meijer A, van Eenige MJ, Verheugt FW. J Am Coll Cardiol; 1995 Nov 15; 26(6):1440-4. PubMed ID: 7594068 [Abstract] [Full Text] [Related]
7. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis. Bauters C, Khanoyan P, McFadden EP, Quandalle P, Lablanche JM, Bertrand ME. Circulation; 1995 Mar 01; 91(5):1410-8. PubMed ID: 7867181 [Abstract] [Full Text] [Related]
8. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. Cannon CP, McCabe CH, Henry TD, Schweiger MJ, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL. J Am Coll Cardiol; 1994 Apr 01; 23(5):993-1003. PubMed ID: 8144799 [Abstract] [Full Text] [Related]
9. Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial). Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis. Veen G, de Boer MJ, Zijlstra F, Verheugt FW. Am J Cardiol; 1999 Oct 01; 84(7):763-7. PubMed ID: 10513770 [Abstract] [Full Text] [Related]
10. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome. van den Bergh PJ, Kievit PC, Brouwer MA, Aengevaeren WR, Veen G, Verheugt FW. Am Heart J; 2009 Mar 01; 157(3):532-40. PubMed ID: 19249425 [Abstract] [Full Text] [Related]
11. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cucherat M, Bonnefoy E, Tremeau G. Cochrane Database Syst Rev; 2000 Mar 01; (2):CD001560. PubMed ID: 10796812 [Abstract] [Full Text] [Related]
12. Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling. Meijer A, Verheugt FW, van Eenige MJ, Werter CJ. Circulation; 1994 Oct 01; 90(4):1706-14. PubMed ID: 7923654 [Abstract] [Full Text] [Related]
15. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E, CLARITY-TIMI 28 Investigators. N Engl J Med; 2005 Mar 24; 352(12):1179-89. PubMed ID: 15758000 [Abstract] [Full Text] [Related]
16. Reocclusion: the flip side of coronary thrombolysis. Verheugt FW, Meijer A, Lagrand WK, Van Eenige MJ. J Am Coll Cardiol; 1996 Mar 15; 27(4):766-73. PubMed ID: 8613601 [Abstract] [Full Text] [Related]
17. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty. Bruna C, Rossetti G, Vado A, Racca E, Steffenino G, Dellavalle A, Ribichini F, Ferrero V, Menardi E, Uslenghi E. G Ital Cardiol; 1998 Jan 15; 28(1):3-11. PubMed ID: 9493040 [Abstract] [Full Text] [Related]